Abstract:Anti-cancer response of cell lines to drugs is in urgent need for individualized precision medical decision-making in the era of precision medicine. Measurements with wet-experiments is time-consuming and expensive and it is almost impossible for wide ranges of application. The design of computational models that can precisely predict the responses between drugs and cell lines could provide a credible reference for further research. Existing methods of response prediction based on matrix factorization or neural networks have revealed that both linear or nonlinear latent characteristics are applicable and effective for the precise prediction of drug responses. However, the majority of them consider only linear or nonlinear relationships for drug response prediction. Herein, we propose a Dual Branch Deep Neural Matrix Factorization (DBDNMF) method to address the above-mentioned issues. DBDNMF learns the latent representation of drugs and cell lines through flexible inputs and reconstructs the partially observed matrix through a series of hidden neural network layers. Experimental results on the datasets of Cancer Cell Line Encyclopedia (CCLE) and Genomics of Drug Sensitivity in Cancer (GDSC) show that the accuracy of drug prediction exceeds state-of-the-art drug response prediction algorithms, demonstrating its reliability and stability. The hierarchical clustering results show that drugs with similar response levels tend to target similar signaling pathway, and cell lines coming from the same tissue subtype tend to share the same pattern of response, which are consistent with previously published studies. As is known, the phenotype of cancer is closely related to gene expression in the human body. In the era of precision medicine, an increasing amount of anti-cancer drug response data is urgently needed for individualized therapy. Measurements with wet-experiments are time-consuming and costly, and computational methods are necessary. Existing methods mainly focused predominantly on linear or nonlinear relationships between cells and drugs for prediction. However, it has been shown that both linear and nonlinear relationships could contribute to more precise response prediction. Here, we propose a Dual Branch Deep Neural Matrix Factorization (DBDNMF) method to better use both linear and nonlinear relationships and the experimental results show that it outperforms state-of-the-art algorithms. Our results suggest that drugs showing similar response levels tend to target similar signaling pathways while cell lines sharing similar response patterns tend to come from the same tissue subtype. The analysis of experimental results may benefit medical decision-making.

Dual-Layer Strengthened Collaborative Topic Regression Modeling for Predicting Drug Sensitivity

Drug Sensitivity Prediction Based on Multi-stage Multi-modal Drug Representation Learning

[Prediction of cancer drug sensitivity based on genomic feature distribution alignment and drug structure information]

Predicting Anticancer Drug Responses Using A Dual-Layer Integrated Cell Line-Drug Network Model

DRN-CDR: A cancer drug response prediction model using multi-omics and drug features

DeepDSC: A Deep Learning Method to Predict Drug Sensitivity of Cancer Cell Lines

SYSTEMATIC ASSESSMENT OF ANALYTICAL METHODS FOR DRUG SENSITIVITY PREDICTION FROM CANCER CELL LINE DATA

DualGCN: a dual graph convolutional network model to predict cancer drug response

Prediction of drug sensitivity based on multi-omics data using deep learning and similarity network fusion approaches

TransCDR: a deep learning model for enhancing the generalizability of cancer drug response prediction through transfer learning and multimodal data fusion for drug representation

DBDNMF: A Dual Branch Deep Neural Matrix Factorization method for drug response prediction

An Improved Anticancer Drug-Response Prediction Based on an Ensemble Method Integrating Matrix Completion and Ridge Regression

A novel heterogeneous network-based method for drug response prediction in cancer cell lines

PDSM-LGCN: Prediction of Drug Sensitivity Associated Micrornas Via Light Graph Convolution Neural Network

A Hybrid Interpolation Weighted Collaborative Filtering Method for Anti-cancer Drug Response Prediction

Prediction of Synergistic Anti-Cancer Drug Combinations Based on Drug Target Network and Drug Induced Gene Expression Profiles

Pathway-Guided Deep Neural Network toward Interpretable and Predictive Modeling of Drug Sensitivity

XGraphCDS: An explainable deep learning model for predicting drug sensitivity from gene pathways and chemical structures

Deep learning-based multi-drug synergy prediction model for individually tailored anti-cancer therapies

Anticancer drug sensitivity prediction in cell lines from baseline gene expression through recursive feature selection

DeepCDR: a Hybrid Graph Convolutional Network for Predicting Cancer Drug Response